New proteasome inhibitors in the treatment of multiple myeloma-Reference-Cited by-同舟云学术

New proteasome inhibitors in the treatment of multiple myeloma

Published:2019-01 Issue:1 Volume:41 Page:76-83
ISSN:2531-1379
Container-title:Hematology, Transfusion and Cell Therapy
language:en
Short-container-title:Hematology, Transfusion and Cell Therapy

Author:

Hungria Vania Tietsche de Moraes,Crusoé Edvan de Queiroz,Bittencourt Rosane Isabel,Maiolino Angelo,Magalhães Roberto José Pessoa,Sobrinho Jairo do Nascimento,Pinto Jorge Vaz,Fortes Ricardo Coutinho,Moreira Eloisa de Sá,Tanaka Paula Yurie

Funder

Takeda Pharmaceuticals

Publisher

Elsevier BV

Subject

Hematology,Immunology and Allergy

Reference56 articles.

1. Multiple myeloma: diagnosis and treatment;Rajkumar;Mayo Clin Proc,2016

2. Prevalence of symptoms in patients with multiple myeloma: a systematic review and meta-analysis;Ramsenthaler;Eur J Haematol,2016

3. Cancer statistics, 2017;Siegel;CA: Cancer J Clin,2017

4. Observational study of multiple myeloma in Latin America;Hungria;Ann Hematol,2017

5. Confirmation of the utility of the International Staging System and identification of a unique pattern of disease in Brazilian patients with multiple myeloma;Hungria;Haematologica,2008

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Proteasome Inhibitor Marizomib Evokes Endoplasmic Reticulum Stress and Promotes Apoptosis in Human Glioblastoma Cells;Pharmaceuticals;2024-08-20

2. Current approach to Waldenström macroglobulinemia;Blood Reviews;2023-11

3. Proteasome inhibitors as anticancer agents;Expert Opinion on Therapeutic Patents;2023-10-30

4. Design and synthesis of amino-substituted N-arylpiperidinyl-based inhibitors of the (immuno)proteasome;Acta Pharmaceutica;2023-09-01

5. BTK Inhibitors and Other Targeted Therapies in Waldenström Macroglobulinemia;Hemato;2023-04-13